Cargando…
Fibroblast Growth Factor 23: Potential Marker of Invisible Heart Damage in Diabetic Population
Two-dimensional speckle-tracking echocardiography (2DSTE) detects myocardial dysfunction despite a preserved left ventricular ejection fraction. Fibroblast growth factor 23 (FGF23) has become a promising biomarker of cardiovascular risk. This study aimed to determine whether FGF23 may be used as a m...
Autores principales: | Kurpas, Anna, Supel, Karolina, Wieczorkiewicz, Paulina, Bodalska Duleba, Joanna, Zielinska, Marzenna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294899/ https://www.ncbi.nlm.nih.gov/pubmed/37371618 http://dx.doi.org/10.3390/biomedicines11061523 |
Ejemplares similares
-
Fibroblast Growth Factor 23 and Cardiovascular Risk in Diabetes Patients—Cardiologists Be Aware
por: Kurpas, Anna, et al.
Publicado: (2022) -
FGF23: A Review of Its Role in Mineral Metabolism and Renal and Cardiovascular Disease
por: Kurpas, Anna, et al.
Publicado: (2021) -
2D Strain Analysis in Myocarditis—Can We Be Any Closer to Diagnose the Acute Phase of the Disease?
por: Supeł, Karolina, et al.
Publicado: (2023) -
Symptomatic Young Adults with ST-Segment Elevation—Acute Coronary Syndrome or Myocarditis: The Three-Factor Diagnostic Model
por: Wieczorkiewicz, Paulina, et al.
Publicado: (2022) -
Acute coronary syndrome versus acute myocarditis in young adults–value of speckle tracking echocardiography
por: Wieczorkiewicz, Paulina, et al.
Publicado: (2022)